Melissa Weber

May 08, 2012

Minimizing and preventing late effects of stem cell transplantation.

June 20, 2011

Lung cancer treatment continues to make strides.

June 14, 2011

Learn tips on figuring out what causes cancer-related fatigue and how to manage it.

March 20, 2011

Calming the effects of radiation on the skin.

December 20, 2010

Studies conflict on bone-building drug's ability to prevent recurrence.

December 09, 2010

In recent years, scientists discovered that an enzyme called CYP2D6 could possibly predict whether a patient would respond to the drug. Small studies aimed at confirming the predictive link, however, have been consistently inconsistent.

December 09, 2010

Adding Afinitor, an mTOR inhibitor, to tamoxifen helped women with metastatic breast cancer live about four months longer without their disease getting worse, according to a study presented Thursday at SABCS.

December 09, 2010

Obese women with breast cancer are at higher risk for recurrence and death, but new findings suggest it may depend on cancer subtype.

December 09, 2010

New studies start to pinpoint the best strategy for treating HER2-positive breast cancer before surgery and lay the groundwork for future clinical trials.

December 09, 2010

Two studies presented at SABCS offer a better understanding of what to do with the information sentinel lymph nodes provide.

December 09, 2010

Findings from the long-awaited AZURE trial show Zometa may prevent recurrence, but not for everyone.

December 09, 2010

Not only is weight training safe, but for women who have had lymph node removal due to breast cancer surgery, it also may reduce the risk of lymphedema by about a third.

December 08, 2010

Every woman with a mutated BRCA1 or BRCA2 gene should have their ovaries removed to lower their risk of ovarian cancer, said Susan Domchek, MD, one of the educational sessions speakers at the 2010 SABCS.

September 17, 2010

New research shows some metastatic breast cancer patients could be receiving the wrong treatment.

September 16, 2010

The latest in cancer prevention, diagnosis & treatment.

September 07, 2010

Oncologists have begun trading in what had become a miracle pill for patients with chronic myeloid leukemia for more potent, newer-generation drugs that appear to work even better as first-line treatment for CML.

June 23, 2010

For patients with stage 3 colorectal cancer and normal KRAS gene activity, Erbitux (cetuximab) did not extend survival when added to chemotherapy.

June 21, 2010

Three drugs, which use different mechanisms to target cancer, highlighted at annual oncology meeting.

June 20, 2010

Researchers have developed a new screening approach that produces very few false positives in postmenopausal women with an average risk of ovarian cancer.

June 16, 2010

A new chemotherapy drug, called eribulin, extended survival by two and a half months in patients with locally recurrent or metastatic breast cancer whose cancers continued to progress despite treatment with numerous other drugs.

June 15, 2010

Continued use of the targeted drug Avastin (bevacizumab), after initial treatment with the drug and chemotherapy, helped slow progression of advanced ovarian cancer, according to a phase 3 study.

June 14, 2010

For metastatic melanoma patients who were out of treatment options, the immune system-targeted drug ipilimumab extended their lives by nearly four months compared with an investigational vaccine called gp100.

April 29, 2010

April 18, 2010

March 17, 2010

March 03, 2010

February 19, 2010

January 26, 2010

January 21, 2010

January 20, 2010